Additionally, the combination of simvastatin with romidepsin synergistically killed bladder cancer cells, with mechanisms involving ER stress induction, AMPK activation, histone acetylation, and enhanced PPARγ expression (Okubo et al., 2021). Here, PPARG is linked to urinary bladder carcinoma.